Patents by Inventor Godrej KHAMBATTA

Godrej KHAMBATTA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods for measuring small molecule affinity to cereblon
    Patent number: 11644461
    Abstract: A complex comprises a CRBN having a europium-anti-his antibody on the N-terminus of the CRBN, and a Cy5-conjugated small molecule, wherein the Cy5-conjugated small molecule binds the CRBN, and uses thereof for identifying therapeutic compounds.
    Type: Grant
    Filed: September 18, 2020
    Date of Patent: May 9, 2023
    Assignee: CELGENE CORPORATION
    Inventors: Philip Paul Chamberlain, Mary Matyskiela, Godrej Khambatta
  • METHODS FOR MEASURING SMALL MOLECULE AFFINITY TO CEREBLON
    Publication number: 20210102938
    Abstract: A complex comprises a CRBN having a europium-anti-his antibody on the N-terminus of the CRBN, and a Cy5-conjugated small molecule, wherein the Cy5-conjugated small molecule binds the CRBN, and uses thereof for identifying therapeutic compounds.
    Type: Application
    Filed: September 18, 2020
    Publication date: April 8, 2021
    Applicant: CELGENE CORPORATION
    Inventors: Philip Paul CHAMBERLAIN, Mary MATYSKIELA, Godrej KHAMBATTA
  • Methods for measuring small molecule affinity to cereblon
    Patent number: 10816544
    Abstract: A complex comprises a CRBN having a europium-anti-his antibody on the N-terminus of the CRBN, and a Cy5-conjugated small molecule, wherein the Cy5-conjugated small molecule binds the CRBN, and uses thereof for identifying therapeutic compounds.
    Type: Grant
    Filed: February 2, 2018
    Date of Patent: October 27, 2020
    Assignee: CELGENE CORPORATION
    Inventors: Philip Paul Chamberlain, Mary Matyskiela, Godrej Khambatta
  • METHODS FOR MEASURING SMALL MOLECULE AFFINITY TO CEREBLON
    Publication number: 20180224435
    Abstract: A complex comprises a CRBN having a europium-anti-his antibody on the N-terminus of the CRBN, and a Cy5-conjugated small molecule, wherein the Cy5-conjugated small molecule binds the CRBN, and uses thereof for identifying therapeutic compounds.
    Type: Application
    Filed: February 2, 2018
    Publication date: August 9, 2018
    Inventors: Philip Paul CHAMBERLAIN, Mary MATYSKIELA, Godrej KHAMBATTA